This content is machine translated Secondary prevention after ACS: individually optimized lipid management Trend towards early combination therapy and new strategies for lowering Lp(a) Secondary prevention after an acute coronary syndrome (ACS) is crucial for improving quality of life and reducing morbidity and mortality rates. Elevated blood lipid levels such as LDL cholesterol and...…
View Post 3 min This content is machine translated LDL cholesterol Bempedoic acid and cardiovascular outcomes in statin intolerant patients Treatment of elevated LDL cholesterol levels is a central component of modern therapy to reduce the risk of serious cardiovascular events in patients with primary or secondary prevention. However, 7%…
View Post 3 min This content is machine translated ASCVD Statin therapy for the prevention of cardiovascular disease in HIV Statin therapy should be initiated in patients with HIV infection aged 40 to 75 years who are at risk of developing atherosclerotic cardiovascular disease (ASCVD). This is according to the…
View Post 8 min This content is machine translated Cholesterol Management Impressive results of PCSK9 inhibitors Cholesterol management was the subject of discussion at the Prevention Summit at the University Hospital Zurich. The new lipid guidelines from the AHA/ACC are generating a lot of criticism. This…
